Literature DB >> 9556700

D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms.

J Uribarri1, M S Oh, H J Carroll.   

Abstract

This report describes a case of d-lactic acidosis observed by the authors and then reviews all case reports of d-lactic acidosis in the literature in order to define its clinical and biochemical features and pathogenetic mechanisms. The report also reviews the literature on metabolism of d-lactic acid in humans. The clinical presentation of d-lactic acidosis is characterized by episodes of encephalopathy and metabolic acidosis. The diagnosis should be considered in a patient who presents with metabolic acidosis and high serum anion gap, normal lactate level, negative Acetest, short bowel syndrome or other forms of malabsorption, and characteristic neurologic findings. Development of the syndrome requires the following conditions 1) carbohydrate malabsorption with increased delivery of nutrients to the colon, 2) colonic bacterial flora of a type that produces d-lactic acid, 3) ingestion of large amounts of carbohydrate, 4) diminished colonic motility, allowing time for nutrients in the colon to undergo bacterial fermentation, and 5) impaired d-lactate metabolism. In contrast to the initial assumption that d-lactic acid is not metabolized by humans, analysis of published data shows a substantial rate of metabolism of d-lactate by normal humans. Estimates based on these data suggest that impaired metabolism of d-lactate is almost a prerequisite for the development of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556700     DOI: 10.1097/00005792-199803000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  48 in total

Review 1.  The neurology of enteric disease.

Authors:  A J Wills; D S N A Pengiran Tengah; G K T Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

2.  Serial transverse enteroplasty for management of refractory D-lactic acidosis in short-bowel syndrome.

Authors:  Biren P Modi; Monica Langer; Christopher Duggan; Heung Bae Kim; Tom Jaksic
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-09       Impact factor: 2.839

3.  D-lactic acidosis and ataxia in a man with Crohn disease.

Authors:  Paul D James; David Black; Ayelet Kuper; Fred Saibil
Journal:  CMAJ       Date:  2010-01-18       Impact factor: 8.262

Review 4.  Probiotics, D-Lactic acidosis, oxidative stress and strain specificity.

Authors:  Luis Vitetta; Samantha Coulson; Michael Thomsen; Tony Nguyen; Sean Hall
Journal:  Gut Microbes       Date:  2017-01-12

Review 5.  Metabolic acidosis: pathophysiology, diagnosis and management.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

Review 6.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

7.  Metabolic acidosis in short bowel syndrome: think D-lactic acid acidosis.

Authors:  Sorin Stanciu; Aminda De Silva
Journal:  BMJ Case Rep       Date:  2018-05-16

8.  Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.

Authors:  Seongseok Yun; Courtney N Walker; Nicole D Vincelette; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-06-09

9.  Post-mortem analysis of lactate concentration in diabetics and metformin poisonings.

Authors:  T Keltanen; T Nenonen; R A Ketola; I Ojanperä; A Sajantila; K Lindroos
Journal:  Int J Legal Med       Date:  2015-09-01       Impact factor: 2.686

10.  Gastric PgCO2 and Pg-aCO2 gap are related to D-lactate and not to L-lactate levels in patients with septic shock.

Authors:  Martijn Poeze; Barbara C J Solberg; Jan Willem M Greve; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-10-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.